Patents by Inventor Burkhard Goke

Burkhard Goke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Exendin improves ?-cell response in subjects with impaired glucose tolerance
    Patent number: 7265087
    Abstract: A composition for the treatment of impaired glucose tolerance (IGT) including a compound which binds to a receptor for glucagon-like peptide-1, and a pharmaceutical carrier. The amount of the compound present is an effective amount to improve pancreatic ?-cell sensitivity to blood glucose levels in a human with IGT. Also, a method for improving the pattern of insulin secretory responses in a human with IGT by administering to the human a composition comprising a compound which binds to a receptor for glucagon-like peptide-1 and a pharmaceutical carrier.
    Type: Grant
    Filed: May 7, 1999
    Date of Patent: September 4, 2007
    Assignee: Amylin Pharmaceuticals, Inc.
    Inventors: Burkhard Göke, Maria Byrne, Thomas R. Coolidge
  • Human appetite control by glucagon-like peptide receptor binding compounds
    Publication number: 20060128627
    Abstract: A composition including a compound which binds to a receptor for glucagon-like peptide-1 and a pharmaceutical carrier. The amount of the compound present is effective to control appetite in a human. Also disclosed is a method for controlling appetite and for reducing food intake in a human by administering to the human a composition comprising a compound which binds to a receptor for glucagon-like peptide-1 and a pharmaceutical carrier.
    Type: Application
    Filed: February 6, 2006
    Publication date: June 15, 2006
    Applicant: Amylin Pharmaceuticals, Inc.
    Inventors: Burkhard Goke, Christoph Beglinger, Thomas Coolidge
  • Human appetite control by glucagon-like peptide receptor binding compounds
    Patent number: 6998387
    Abstract: A composition including a compound which binds to a receptor for glucagon-like peptide-1 and a pharmaceutical carrier. The amount of the compound present is effective to control appetite in a human. Also disclosed is a method for controlling appetite and for reducing food intake in a human by administering to the human a composition comprising a compound which binds to a receptor for glucagon-like peptide-1 and a pharmaceutical carrier.
    Type: Grant
    Filed: March 16, 1999
    Date of Patent: February 14, 2006
    Assignee: Amylin Pharmaceuticals, Inc.
    Inventors: Burkhard Goke, Christoph Beglinger, Thomas R. Coolidge